Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-24-057527
Filing Date
2024-05-06
Accepted
2024-05-06 17:12:40
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2413238d3_defa14a.htm DEFA14A 24650
  Complete submission text file 0001104659-24-057527.txt   25748
Mailing Address 101 LINDENWOOD DRIVE, SUITE 225 MALVERN PA 19355
Business Address 101 LINDENWOOD DRIVE, SUITE 225 MALVERN PA 19355 484-875-3192
Annovis Bio, Inc. (Filer) CIK: 0001477845 (see all company filings)

EIN.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39202 | Film No.: 24918567
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)